Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TTU08.801)
Received: 14 September 2018
Accepted: 11 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: The ethics committee at Charité, University Medicine Berlin, Germany, approved this study (EA/018/14). Surveillance was performed in accordance with the German Infection Protection Act and did not require patient consent.(9).
: Not applicable.
: No competing interests unless stated.MJGTV is a consultant to: Alb Fils Kliniken, Astellas Pharma, MaaT Pharma, MSD/Merck; has served with the speakers’ bureau of: Astellas Pharma, Basilea, Gilead Sciences, Merck/MSD, Organobalance and Pfizer; received research funding from: 3 M, Astellas Pharma, DaVolterra, Gilead Sciences, Merck/MSD, Morphochem, Organobalance, and Seres Therapeutics.HS reports grants from Bundesministerium für Bildung und Forschung (BMBF), the German Center for Infection Research (DZIF), Cubist, and Novartis, and personal fees from Astellas-Basilea, Cubist, Durata, Genentech, Gilead, MSD, Roche Pharma, and Tetraphase.JKMK received research and travel grants from Novartis, bioMérieux, Bayer Vital, and Alere and served as consultant or speaker for bioMérieux, Novartis,and Pfizer.JZ received a speaker’s honorarium from Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.